Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Weill Medical College of Cornell University
University of California, San Francisco
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
AIDS Malignancy Consortium
AIDS Malignancy Consortium
University Hospital Virgen de las Nieves